粪肠球菌临床分离株中ParC和GyrA蛋白改变与对九种不同氟喹诺酮类药物耐药性的关联
Association of alterations in ParC and GyrA proteins with resistance of clinical isolates of Enterococcus faecium to nine different fluoroquinolones.
作者信息
Brisse S, Fluit A C, Wagner U, Heisig P, Milatovic D, Verhoef J, Scheuring S, Köhrer K, Schmitz F J
机构信息
Eijkman-Winkler Institute, Utrecht University, 3584 CX, Utrecht, The Netherlands.
出版信息
Antimicrob Agents Chemother. 1999 Oct;43(10):2513-6. doi: 10.1128/AAC.43.10.2513.
Abstract
The parC and gyrA genes of 73 ciprofloxacin-resistant and 6 ciprofloxacin-susceptible Enterococcus faecium clinical isolates were partly sequenced. Alterations in ParC and GyrA, possibly in combination with other resistance mechanisms, severely restricted the in vitro activities of the nine quinolones tested. For all isolates, clinafloxacin and sitafloxacin showed the best activities.
摘要
对73株耐环丙沙星和6株环丙沙星敏感的屎肠球菌临床分离株的parC和gyrA基因进行了部分测序。ParC和GyrA的改变，可能与其他耐药机制共同作用，严重限制了所测试的9种喹诺酮类药物的体外活性。对于所有分离株，克林沙星和司帕沙星显示出最佳活性。
相似文献
1
Association of alterations in ParC and GyrA proteins with resistance of clinical isolates of Enterococcus faecium to nine different fluoroquinolones.粪肠球菌临床分离株中ParC和GyrA蛋白改变与对九种不同氟喹诺酮类药物耐药性的关联
Antimicrob Agents Chemother. 1999 Oct;43(10):2513-6. doi: 10.1128/AAC.43.10.2513.
2
Alterations in GyrA and ParC associated with fluoroquinolone resistance in Enterococcus faecium.粪肠球菌中与氟喹诺酮耐药性相关的GyrA和ParC改变。
Antimicrob Agents Chemother. 1999 Apr;43(4):947-9. doi: 10.1128/AAC.43.4.947.
3
DNA gyrase and topoisomerase IV are dual targets of clinafloxacin action in Streptococcus pneumoniae.DNA 回旋酶和拓扑异构酶IV是环丙沙星作用于肺炎链球菌的双重靶点。
Antimicrob Agents Chemother. 1998 Nov;42(11):2810-6. doi: 10.1128/AAC.42.11.2810.
4
Correlation of in vitro susceptibilities to newer quinolones of naturally occurring quinolone-resistant Neisseria gonorrhoeae strains with changes in GyrA and ParC.天然存在的喹诺酮耐药淋病奈瑟菌菌株对新型喹诺酮类药物的体外敏感性与GyrA和ParC变化的相关性
Antimicrob Agents Chemother. 2001 Mar;45(3):734-8. doi: 10.1128/AAC.45.3.734-738.2001.
5
Type II topoisomerase mutations in fluoroquinolone-resistant clinical strains of Pseudomonas aeruginosa isolated in 1998 and 1999: role of target enzyme in mechanism of fluoroquinolone resistance.1998年和1999年分离出的耐氟喹诺酮铜绿假单胞菌临床菌株中的II型拓扑异构酶突变：靶酶在氟喹诺酮耐药机制中的作用
Antimicrob Agents Chemother. 2001 Aug;45(8):2263-8. doi: 10.1128/AAC.45.8.2263-2268.2001.
6
Activities of newer fluoroquinolones against Streptococcus pneumoniae clinical isolates including those with mutations in the gyrA, parC, and parE loci.新型氟喹诺酮类药物对肺炎链球菌临床分离株的活性，包括那些gyrA、parC和parE基因座发生突变的分离株。
Antimicrob Agents Chemother. 1999 Feb;43(2):329-34. doi: 10.1128/AAC.43.2.329.
7
Detection of mutations in the gyrA and parC genes in quinolone-resistant clinical isolates of Enterobacter cloacae.阴沟肠杆菌喹诺酮耐药临床分离株中gyrA和parC基因突变的检测
J Antimicrob Chemother. 1997 Oct;40(4):543-9. doi: 10.1093/jac/40.4.543.
8
Development of fluoroquinolone resistance and mutations involving GyrA and ParC proteins among Neisseria gonorrhoeae isolates in Japan.日本淋病奈瑟菌分离株中氟喹诺酮耐药性的发展以及涉及GyrA和ParC蛋白的突变
J Urol. 1998 Jun;159(6):2215-9. doi: 10.1016/S0022-5347(01)63308-1.
9
Quinolone-resistant Neisseria gonorrhoeae: correlation of alterations in the GyrA subunit of DNA gyrase and the ParC subunit of topoisomerase IV with antimicrobial susceptibility profiles.耐喹诺酮淋病奈瑟菌：DNA 回旋酶 GyrA 亚基和拓扑异构酶 IV 的 ParC 亚基改变与抗菌药物敏感性谱的相关性
Antimicrob Agents Chemother. 1996 Apr;40(4):1020-3. doi: 10.1128/AAC.40.4.1020.
10
Alterations in the GyrA subunit of DNA gyrase and the ParC subunit of DNA topoisomerase IV associated with quinolone resistance in Enterococcus faecalis.粪肠球菌中与喹诺酮耐药性相关的DNA回旋酶GyrA亚基和DNA拓扑异构酶IV的ParC亚基的改变。
Antimicrob Agents Chemother. 1998 Feb;42(2):433-5. doi: 10.1128/AAC.42.2.433.
引用本文的文献
1
Virulence gene detection and antimicrobial resistance analysis of Enterococcus faecium in captive giant pandas (Ailuropoda melanoleuca) in China.中国圈养大熊猫（Ailuropoda melanoleuca）粪肠球菌的毒力基因检测及耐药性分析。
Acta Vet Scand. 2023 Feb 3;65(1):4. doi: 10.1186/s13028-023-00668-z.
2
Identification and characterization of resistance and pathogenicity of . in samples of donor breast milk.供体母乳样本中……的抗性和致病性的鉴定与表征。 （注：原文中“of.”部分内容缺失，导致翻译不够完整准确）
World J Clin Pediatr. 2020 Nov 19;9(3):53-62. doi: 10.5409/wjcp.v9.i3.53.
3
Association of mutation patterns in GyrA and ParC genes with quinolone resistance levels in lactic acid bacteria.乳酸杆菌中GyrA和ParC基因突变模式与喹诺酮耐药水平的关联
J Antibiot (Tokyo). 2015 Feb;68(2):81-7. doi: 10.1038/ja.2014.113. Epub 2014 Sep 10.
4
Antibiotic resistances of starter and probiotic strains of lactic acid bacteria.乳酸菌发酵剂和益生菌菌株的抗生素抗性
Appl Environ Microbiol. 2007 Feb;73(3):730-9. doi: 10.1128/AEM.02105-06. Epub 2006 Nov 22.
5
High-level ciprofloxacin resistance from point mutations in gyrA and parC confined to global hospital-adapted clonal lineage CC17 of Enterococcus faecium.屎肠球菌中由gyrA和parC点突变导致的高水平环丙沙星耐药性局限于全球医院适应性克隆谱系CC17。
J Clin Microbiol. 2006 Mar;44(3):1059-64. doi: 10.1128/JCM.44.3.1059-1064.2006.
6
Automated ribotyping of vancomycin-resistant Enterococcus faecium isolates.耐万古霉素屎肠球菌分离株的自动化核糖体分型
J Clin Microbiol. 2002 Jun;40(6):1977-84. doi: 10.1128/JCM.40.6.1977-1984.2002.
7
Gatifloxacin: a review of its use in the management of bacterial infections.加替沙星：其在细菌感染治疗中的应用综述
Drugs. 2002;62(1):169-207. doi: 10.2165/00003495-200262010-00007.
本文引用的文献
1
Quinolone resistance by mutations in chromosomal gyrase genes. Just the tip of the iceberg?染色体回旋酶基因突变导致的喹诺酮耐药性。这只是冰山一角吗？
J Antimicrob Chemother. 1998 Dec;42(6):683-8. doi: 10.1093/jac/42.6.683.
2
Primary targets of fluoroquinolones in Streptococcus pneumoniae.肺炎链球菌中氟喹诺酮类药物的主要作用靶点。
Antimicrob Agents Chemother. 1999 Feb;43(2):410-2. doi: 10.1128/AAC.43.2.410.
3
Identification of an efflux pump gene, pmrA, associated with fluoroquinolone resistance in Streptococcus pneumoniae.鉴定与肺炎链球菌氟喹诺酮耐药性相关的外排泵基因pmrA。
Antimicrob Agents Chemother. 1999 Jan;43(1):187-9. doi: 10.1128/AAC.43.1.187.
4
The prevalence of low- and high-level mupirocin resistance in staphylococci from 19 European hospitals.来自19家欧洲医院的葡萄球菌中低水平和高水平莫匹罗星耐药性的流行情况。
J Antimicrob Chemother. 1998 Oct;42(4):489-95. doi: 10.1093/jac/42.4.489.
5
DNA gyrase and topoisomerase IV are dual targets of clinafloxacin action in Streptococcus pneumoniae.DNA 回旋酶和拓扑异构酶IV是环丙沙星作用于肺炎链球菌的双重靶点。
Antimicrob Agents Chemother. 1998 Nov;42(11):2810-6. doi: 10.1128/AAC.42.11.2810.
6
The effects of increasing levels of quinolone resistance on in-vitro activity of four quinolones.
J Antimicrob Chemother. 1998 Aug;42(2):179-87. doi: 10.1093/jac/42.2.179.
7
Alterations in topoisomerase IV and DNA gyrase in quinolone-resistant mutants of Mycoplasma hominis obtained in vitro.体外获得的人型支原体喹诺酮耐药突变体中拓扑异构酶IV和DNA促旋酶的改变。
Antimicrob Agents Chemother. 1998 Sep;42(9):2304-11. doi: 10.1128/AAC.42.9.2304.
8
Current susceptibilities of staphylococci to glycopeptides determined as part of an international resistance surveillance programme. Sentry Antimicrobial Surveillance Program.
J Antimicrob Chemother. 1998 Jul;42(1):119-21. doi: 10.1093/jac/42.1.119.
9
In vitro activities of six fluoroquinolones against Canadian isolates of vancomycin-sensitive and vancomycin-resistant Enterococcus species.六种氟喹诺酮类药物对加拿大万古霉素敏感和耐药肠球菌菌株的体外活性
Diagn Microbiol Infect Dis. 1998 Jun;31(2):343-7. doi: 10.1016/s0732-8893(98)00019-4.
10
Characterization of grlA, grlB, gyrA, and gyrB mutations in 116 unrelated isolates of Staphylococcus aureus and effects of mutations on ciprofloxacin MIC.116株不相关金黄色葡萄球菌分离株中grlA、grlB、gyrA和gyrB基因突变特征及突变对环丙沙星最低抑菌浓度的影响
Antimicrob Agents Chemother. 1998 May;42(5):1249-52. doi: 10.1128/AAC.42.5.1249.
Zotero 插件